Brain

Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing medicines…

1 year ago

Annovis Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer’s Disease

MALVERN, Pa., Feb. 05, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"),…

1 year ago

Grogo Launches an Innovative App that Transforms Screen Time into Brain-Boosting Breaks for Kids

This New Edutainment Tool for Families is now Available on iOS (iPhone and iPad) and Android phones CHICAGO, Feb. 4,…

1 year ago

Zafrens Expands Investor Syndicate to Scale Revolutionary Drug Discovery Platform

SAN DIEGO, Feb. 4, 2025 /PRNewswire/ -- Zafrens, a pioneering biotech company transforming drug discovery, welcomes imec.xpand to its Series…

1 year ago

New Data Presented at the International Stroke Conference Further Validates Treatment Impact of Brainomix 360

•  This latest research builds upon the growing body of evidence demonstrating the unique impact of Brainomix's AI-powered software to…

1 year ago

Opera introduces Opera Air – the first browser to actively improve your wellbeing

OSLO, Norway, Feb. 4, 2025 /PRNewswire/ -- The Norwegian browser maker Opera [NASDAQ: OPRA] is introducing Opera Air, the first browser…

1 year ago

Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease

ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced…

1 year ago

Microbot Medical® Announces Late-Breaking Abstract Acceptance at the Society of Interventional Radiology Annual Meeting

Acceptance reflects the high interest of the SIR scientific committee on the emerging role of endovascular roboticsBRAINTREE, Mass., Feb. 04,…

1 year ago

Blue Cross Blue Shield of Massachusetts Publishes Positive Reimbursement Policy for the Nerivio® REN Wearable for Acute and Preventive Treatment of Migraine

Nearly three million members of the largest health insurance plan in Massachusetts are now eligible for reimbursement when prescribed with…

1 year ago

Appointment of Dr. Bryan Jones as an Advisor to Lead Sol-Gel Special Projects

Vancouver, British Columbia--(Newsfile Corp. - February 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), (the "Company"…

1 year ago